HSBC Downgrades Qiagen NV(QGEN.US) to Hold Rating, Cuts Target Price to $49
Qiagen Analyst Ratings
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating, Announces Target Price $55
Berenberg Lifts Price Target on Qiagen to EUR54.90 From EUR54.20, Keeps Buy Rating
Qiagen Analyst Ratings
BofA Securities Maintains Qiagen NV(QGEN.US) With Buy Rating
TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Raises Target Price to $51
Goldman Sachs Maintains Qiagen NV(QGEN.US) With Buy Rating
Qiagen Upgraded at Wolfe on Valuation Discount
Qiagen Analyst Ratings
Wolfe Research Upgrades Qiagen to Outperform, Announces $50 Price Target
CORRECTION : JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $54 -Analyst Name Updated (Article Originally Published on 18th June)
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $54
Qiagen Analyst Ratings
Qiagen Analyst Ratings
UBS Sticks to Its Hold Rating for Qiagen (QGEN)
Qiagen Analyst Ratings
Citigroup Maintains Buy on Qiagen, Lowers Price Target to $60
Qiagen Analyst Ratings
Stifel Nicolaus Sticks to Their Hold Rating for Qiagen (QGEN)